BIOAFFINITY TECHNOLOGIES INC (BIAF)

US09076W1099 - Common Stock

2.53  +0.16 (+6.75%)

After market: 2.48 -0.05 (-1.98%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
2.53M0.000.000.00
Cost Of Goods
1.74M0.00N/AN/A
Gross Profit
791.62K0.00N/AN/A
Operating Expenses
8.76M4.01M2.21M2.60M
Research and Development
1.72M1.29M1.33M1.61M
Selling, General, and Administrative Expenses
6.79M2.73M880.00K990.00K
Operating Income
-7.97M-4.01M-2.21M-2.60M
Interest Income/Expense
85.00K-4.35M-4.36M-4.66M
Other Income/Expense
-27.80KN/AN/AN/A
Non Recurring Items
0.00210.00K240.00K0.00
Income Before Taxes
-7.92M-8.15M-6.32M-7.27M
Income Tax
20.99K0.000.000.00
Net Income
-7.94M-8.15M-6.33M-7.27M
EBITDA
-7.72M-4.00MN/A-2.58M
 
Per Share Data
EPS Diluted Total Ops
-0.91-1.81-2.32-2.66
 
Statistics
Gross Profit Margin
31.26%N/AN/AN/A
Profit Margin
-313.41%N/AN/AN/A
Operating Profit Margin
-314.84%N/AN/AN/A

All data in USD

Charts